- Home
- / Parmax Pharma
Parmax Pharma
Stock Price
₹46
2024-10-29
Market Capitalization
₹172.5 M
2024-10-29
Revenue
₹282 M
FY, 2025
Parmax Pharma Summary
Company Summary
- Overview
- Parmax Pharma is a manufacturer and distributor of pharmaceutical drugs and chemicals. It offers tablets, capsules, ointments, injectables, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1994
- Website
- http://www.parmaxpharma.com
- Cybersecurity rating
Table of Contents
Parmax Pharma Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹43.3M
- Gross profit (Q3, 2026)
- ₹12.3M
- Net income (Q3, 2026)
- (₹7.3M)
- Cash (Q2, 2026)
- ₹1.1M
- EBIT (Q3, 2026)
- (₹4.6M)
- Enterprise value
- $286.5M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026